All Stories

  1. Continuous Interstitial Glucose Monitoring through a Long-Term Subcutaneous Implantable Sensor during Pregnancy in Type 1 Diabetes: A Two- Patient Case Report

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, August 2025, Bentham Science Publishers

    Dr Antonio C Bossi

  2. Diabetic Ketoacidosis: Considerations and Residual Controversies in Management After the 2024 ADA, EASD, JBDS, AACE, and DST Joint Consensus

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, April 2025, Bentham Science Publishers

    Dr Antonio C Bossi

  3. IDegLira improves time in range in a cohort of patients with type 2 diabetes: TiREX study

    Article • Acta Diabetologica, September 2024, Springer Science + Business Media

    Dr Antonio C Bossi

  4. COVID-19 vaccines and blood glucose control: Friend or foe?

    Article • Human Vaccines & Immunotherapeutics, June 2024, Taylor & Francis

    Dr Antonio C Bossi

  5. Patient-Support Program in Diabetes Care During the Covid-19 Pandemic: An Italian Multicentric Experience

    Article • Patient Preference and Adherence, January 2022, Taylor & Francis

    Dr Antonio C Bossi

  6. Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

    Article • Acta Diabetologica, October 2021, Springer Science + Business Media

    Dr Antonio C Bossi

  7. Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study

    Article • PLoS Medicine, July 2021, PLOS

    Dr Antonio C Bossi

  8. A Response To: Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

    Article • Diabetes Therapy, October 2020, Springer Science + Business Media

    Dr Antonio C Bossi

  9. ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide

    Article • Diabetes Therapy, September 2020, Springer Science + Business Media

    Dr Antonio C Bossi, Giovanni Veronesi

  10. PERsistent Sitagliptin treatment & Outcomes (PERS&O 2.0) study, long-term results: a real-world observation on DPP4-inhibitor effectiveness

    Article • BMJ Open Diabetes Research & Care, September 2020, BMJ

    Dr Antonio C Bossi

  11. Insulin Management for Type 1 Diabetic Patients During Social Alcohol Consumption: The SPRITZ Study

    Article • Current Diabetes Reviews, June 2020, Bentham Science Publishers

    Dr Antonio C Bossi, Giovanni Veronesi

  12. Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends

    Article • Diabetes Therapy, May 2020, Springer Science + Business Media

    Dr Antonio C Bossi

  13. Pasta Consumption and Connected Dietary Habits: Associations with Glucose Control, Adiposity Measures, and Cardiovascular Risk Factors in People with Type 2 Diabetes—TOSCA.IT Study

    Article • Nutrients, December 2019, MDPI AG

    Dr Antonio C Bossi, Dr Marilena Vitale

  14. La gestione del paziente diabetico tra presente e futuro

    Article • AboutOpen, October 2017, Aboutscience Srl

    Dr Antonio C Bossi

  15. A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY Study

    Article • Current Diabetes Reviews, October 2016, Bentham Science Publishers

    Dr Antonio C Bossi, Giovanni Veronesi

  16. Skin Oil Staining to Avoid Infusion Set Cannula Crimping

    Article • Journal of Diabetes Science and Technology, September 2016, SAGE Publications

    Dr Antonio C Bossi

  17. Comment on Muraki et al. Potato Consumption and Risk of Type 2 Diabetes: Results From Three Prospective Cohort Studies. Diabetes Care 2016;39:376–384

    Article • Diabetes Care, August 2016, American Diabetes Association

    Dr Antonio C Bossi

  18. PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment

    Article • BMJ Open Diabetes Research & Care, July 2016, BMJ

    Dr Antonio C Bossi

  19. Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis

    Article • Clinical Diabetes and Endocrinology, November 2015, Springer Science + Business Media

    Dr Antonio C Bossi, Giovanni Veronesi

  20. Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey

    Article • Diabetes Technology & Therapeutics, February 2015, Mary Ann Liebert Inc

    Dr Antonio C Bossi, Prof Marco Giorgio Baroni

  21. Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study

    Article • Current Medical Research and Opinion, December 2014, Informa Healthcare

    Dr Antonio C Bossi

  22. GLP-1 response to 2 energy-matched snacks

    Article • American Journal of Clinical Nutrition, October 2014, American Society for Nutrition

    Dr Antonio C Bossi

  23. Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial

    Article • The Lancet Diabetes & Endocrinology, September 2013, Elsevier

    Dr Antonio C Bossi

  24. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

    Article • Kidney International, July 2013, Elsevier

    Dr Antonio C Bossi

  25. ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy

    Article • Diabetes, June 2013, American Diabetes Association

    Dr Antonio C Bossi

  26. Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2012, Elsevier

    Dr Antonio C Bossi

  27. Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes

    Article • Journal of the American Society of Nephrology, August 2012, American Society of Nephrology

    Dr Antonio C Bossi

  28. Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes

    Article • Diabetes Care, July 2012, American Diabetes Association

    Dr Antonio C Bossi

  29. Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets

    Article • Diabetes Care, May 2012, American Diabetes Association

    Dr Antonio C Bossi, Prof Marco Giorgio Baroni

  30. Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial

    Article • Hypertension, September 2011, Wolters Kluwer Health

    Dr Antonio C Bossi

  31. Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients

    Article • European Journal of Pharmacology, September 2011, Elsevier

    Dr Antonio C Bossi, Dr Aldo Bonaventura

  32. Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial

    Article • Journal of Hypertension, February 2011, Wolters Kluwer Health

    Associate Professor Borislav D Dimitrov, Dr Antonio C Bossi

  33. Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial

    Article • Diabetes Care, June 2010, American Diabetes Association

    Dr Antonio C Bossi

  34. Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial

    Article • Journal of Ophthalmology, January 2010, Hindawi Publishing Corporation

    Dr Antonio C Bossi

  35. Impact of the PPAR- 2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT

    Article • Diabetes, August 2009, American Diabetes Association

    Dr Antonio C Bossi

  36. Bent Needles: Another Problem in Glycemic Control

    Article • Diabetes Care, September 2008, American Diabetes Association

    Dr Antonio C Bossi

  37. Preventing Microalbuminuria in Type 2 Diabetes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2004, New England Journal of Medicine (NEJM/MMS)

    Dr Antonio C Bossi

  38. Ondasentron in the Treatment of Diabetic Diarrhea

    Article • Diabetes Care, May 1994, American Diabetes Association

    Dr Antonio C Bossi

  39. Side-effects, structure, and H2-receptor antagonists

    Article • The Lancet, May 1992, Elsevier

    Dr Antonio C Bossi

  40. Epidural Spinal Electrostimulatory System (ESES) in the Management of Diabetic Foot and Peripheral Arteriopathies

    Article • Pacing and Clinical Electrophysiology, April 1989, Wiley

    Dr Antonio C Bossi

  41. UNCOATED VERSUS COATED 5-AMINOSALICYLIC ACID IN CROHN'S DISEASE

    Article • The Lancet, February 1989, Elsevier

    Dr Antonio C Bossi

  42. Ano-rectal manometry as an evaluating test for impaired ano-rectal function in diabetes mellitus

    Article • October 1986, Springer Science + Business Media

    Dr Antonio C Bossi

  43. Clinical and instrumental diagnosis of autonomic neuropathy in insulin-dependent diabetes

    Article • October 1982, Springer Science + Business Media

    Dr Antonio C Bossi